The CAE Air1 ventilator (CNW Group/CAE INC.)
CAE (NYSE:CAE) announced today that its CAE Air1 ventilator received certification from Health Canada and is set to treat people with COVID-19.
Two months ago, the Canadian government issued a contract to CAE to manufacture and supply 10,000 ventilators amid the COVID-19 pandemic. The devices deliver pressure control, volume control and pressure support ventilation using room air or pressured oxygen.
The CAE Air1 ventilator includes an intuitive touchscreen interface and is bundled with on-demand ventilator training, adaptive e-learning modules related to COVID-19 patient management and 24/7 customer support.
Montreal-based CAE said in a news release that it will begin shipping hundreds of CAE Air1 machines to the Canadian government every week.
“Since the beginning of the pandemic, CAE was the first to receive certification from Health Canada for an entirely new ventilator,” CAE president & CEO Marc Parent said in the release. “It was created and manufactured in Canada, and we are proud that it will help save lives in the fight against COVID-19. The agility shown by CAE in designing and succeeding to have the CAE Air1 ventilator certified in a fraction of the usual time is a testament to the strength of CAE’s innovation, engineering talent, and advanced manufacturing capabilities.
“I am proud of our team for rising to this humanitarian challenge and strengthening Canada’s self-sufficiency in the medical field during these unprecedented times.”